Search Results

Protein may be responsible for bladder cancer metastasis.

• Source: Urology Times. 2006, Vol. 34, Issue 10, pages. 1

Record details

Analysis yields potential precision medicine path in mHSPC

• Authors : Ternyila, Danielle

• Source: Urology Times. May, 2020, Vol. 48 Issue 5, p21, 5 p.

Record details

Protein may be responsible for bladder cancer metastasis

• Source: Urology Times. August 15, 2006, Vol. 34 Issue 10, p3, 1 p.

Record details

Metastatic Castration-Resistant Prostate Cancer: Real-World Implications of the CARD Study

• Source: Urology Times. November, 2020, Vol. 48 Issue 11, p28, 3 p.

Record details

PET use in prostate cancer widens, but questions remain

• Authors : Frydenberg, Mark

• Source: Urology Times. August, 2019, Vol. 47 Issue 8, p32, 3 p.

Record details

Importance of identifying the early emergence of metastatic disease in prostate cancer

• Authors : Pieczonka, Christopher M.; Renzulli, Joseph F., II

• Source: Urology Times. September, 2017, Vol. 45 Issue 10, p2, 6 p.

Record details

Atrasentan delays progression time of metastatic PCa: delayed bone pain provides statistically significant impact on quality of life.

• Authors : Bankhead, Charles

• Source: Urology Times. 2004, Vol. 32, Issue 13, pages. 14

Record details

Analysis further refines delivery of new therapies for metastatic CRPC

• Authors : Thrasher, J. Brantley

• Source: Urology Times. September, 2019, Vol. 47 Issue 9

Record details

Durvalumab/tremelimumab combination fails to meet OS end points: Tremelimumab appears to bolster anti-tumor activity of durvalumab, secondary analyses suggest

• Authors : Saylor, Benjamin P.

• Source: Urology Times. October, 2020, Vol. 48 Issue 10, p29, 2 p.

Record details

Cabozantinib shows intriguing activity in heavily pretreated urothelial carcinoma: Objective responsive rate of 19% observed in cohort of patients with metastatic UC

• Authors : Broderick, Jason M.

• Source: Urology Times. September, 2020, Vol. 48 Issue 9, p22, 2 p.

Record details